From: Serum heat shock protein 47 levels in patients with drug-induced lung disease
 | Improved without glucocorticoid | Glucocorticoid needed | Pvalue | ||||
---|---|---|---|---|---|---|---|
 | (N = 18) | (N = 29) |  | ||||
 |  |  | [n] |  |  | [n] |  |
Age (years) | 68.5 | (34-84) | [18] | 68.0 | (36-80) | [29] | N.S. |
Sex (male/female) | 13/5 | Â | [18] | 17/12 | Â | [29] | N.S. |
Smoking (s/ex/n) | 1/12/5 | Â | [18] | 4/16/9 | Â | [29] | N.S. |
HRCT patterns | Â | Â | [18] | Â | Â | [29] | 0.05 |
  OP | 3 |  |  | 1 |  |  |  |
  NSIP | 11 |  |  | 13 |  |  |  |
  HP | 4 |  |  | 7 |  |  |  |
  DAD | 0 |  |  | 8 |  |  |  |
Mortality rate at 30Â days (%) | 0.0 | Â | Â | 10.3 | Â | Â | N.S. |
Hematologic data | Â | Â | Â | Â | Â | Â | Â |
  WBC (/mm3) | 6300 | (3500-14600) | [18] | 7400 | (3500-20800) | [28] | N.S. |
  Hb (g/dL) | 12.3 | (8.5-14.3) | [18] | 10.9 | (7.9-16.2) | [28] | N.S. |
  Plt (×104/mm3) | 21.5 | (12.5-34.1) | [18] | 25.3 | (8.9-46.9) | [28] | N.S. |
Serum markers | Â | Â | Â | Â | Â | Â | Â |
  KL-6 (U/mL) | 601.0 | (264-2115) | [16] | 531.5 | (144-3884) | [26] | N.S. |
  SP-A (ng/mL) | 52.0 | (35.9-141) | [15] | 89.8 | (43.2-310) | [21] | 0.02 |
  SP-D (ng/mL) | 158.0 | (23-653) | [15] | 175.0 | (33-753) | [25] | N.S. |
  HSP47 (pg/mL) | 460.2 | (61.9-1631) | [18] | 1023.0 | (100.5-2843.9) | [29] | 0.003 |
Respiratory parameters | Â | Â | [17] | Â | Â | [27] | Â |
  P/F ratio (mmHg) | 409.0 | (260-542.8) |  | 307.3 | (71-523.8) |  | 0.005 |
  A-a DO2 (mm/Hg) | 15.9 | (-9.5-69.1) |  | 37.8 | (-11.4-474.7) |  | 0.007 |
BAL fluid findings | Â | Â | [16] | Â | Â | [24] | Â |
  Total cell count (×105/mL) | 4.4 | (1.44-15.5) |  | 5.4 | (1.27-54.9) |  | N.S. |
  Macrophages (%) | 65.3 | (4.3-85.4) |  | 37.3 | (4-94.8) |  | N.S. |
  Lymphocytes (%) | 26.6 | (7.7-95.3) |  | 34.8 | (1.7-82) |  | N.S. |
  Neutrophils (%) | 3.2 | (0-13.6) |  | 3.0 | (0-93.6) |  | N.S. |
  Eosinophils (%) | 2.1 | (0-29.9) |  | 1.8 | (0-50.8) |  | N.S. |
  CD4/8 ratio | 0.91 | (0.14-7.05) |  | 1.59 | (0.14-10.4) |  | N.S. |